Lehmann Martin, Zarbock Alexander, Rossaint Jan
Klinik für Anästhesiologie, operative Intensivmedizin und Schmerztherapie, Universitätsklinikum Münster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Deutschland.
Anaesthesiologie. 2022 Oct;71(10):741-749. doi: 10.1007/s00101-022-01197-6. Epub 2022 Sep 5.
Acutely occurring organ damage significantly contributes to morbidity and mortality in the perioperative context.
This article highlights new clinical perspectives on how perioperative organ damage can be prevented and ameliorated by influencing the high mobility group box 1 protein (HMGB1) signaling.
A MEDLINE search was performed in the fields of clinical and basic research. The presentation of basic mechanisms of perioperative organ damage and the discussion of the importance of HMGB1 in prevention and treatment by pharmaceutical and nonpharmaceutical interventions are the focus of the review.
The HMGB1 is a central element in the pathogenesis of septic and aseptic inflammation-induced organ damage. Remote ischemic preconditioning (RIPC) and dexmedetomidine are highly effective approaches to mitigate or prevent organ damage.
The RIPC and dexmedetomidine offer protective properties in ischemia-reperfusion injury as well as in inflammation-related organ damage, which are mediated by HMGB1, among others. This effectively protects the kidneys, heart, lungs, liver and brain. The application of these concepts should be considered in routine clinical practice.
急性发生的器官损伤在围手术期对发病率和死亡率有显著影响。
本文重点介绍关于如何通过影响高迁移率族蛋白B1(HMGB1)信号通路来预防和改善围手术期器官损伤的新临床观点。
在临床和基础研究领域进行了MEDLINE检索。本综述重点介绍围手术期器官损伤的基本机制,并讨论HMGB1在药物和非药物干预预防和治疗中的重要性。
HMGB1是脓毒症和无菌性炎症诱导的器官损伤发病机制中的核心要素。远程缺血预处理(RIPC)和右美托咪定是减轻或预防器官损伤的高效方法。
RIPC和右美托咪定在缺血再灌注损伤以及炎症相关器官损伤中具有保护作用,其中包括由HMGB1介导的损伤。这能有效保护肾脏、心脏、肺、肝脏和大脑。在常规临床实践中应考虑应用这些理念。